Avsnitt Immutep refocuses efti development on head and neck cancer and soft tissue sarcoma Latest Interviews - Finance News Network Spela Dela
17 Sept 2026 - CEO Marc Voigt outlines Immutep’s focused clinical strategy, ongoing TACTI-004 analysis and plans to return efti to the clinic in 2027. Rss Apple Podcaster →